Does statin use affect the risk of developing prostate cancer?

Nature Clinical Practice Urology

Volumn 6, Issue 2, 2009, Pages 70-71

  Platz, Elizabeth A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ANTIINFLAMMATORY ACTIVITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL SURVIVAL; CLINICAL TRIAL; DRUG SAFETY; DRUG SENSITIVITY; DRUG USE; HUMAN; HYPERCHOLESTEROLEMIA; METASTASIS INHIBITION; NOTE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RISK BENEFIT ANALYSIS; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 60149083868     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1295     Document Type: Note

References (7)

1. Agalliu I et al. (2008) Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 168: 250-260
2. Platz EA (2007) Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer. Cancer Epidemiol Biomarkers Prev 16: 2175-2180
3. Friedman GD et al. (2008) Screening statins for possible carcinogenic risk: Up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 17: 27-36
4. Boudreau DM et al. (2008) Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control 19: 767-774
5. Kuoppala J et al. (2008) Statins and cancer: A systematic review and meta-analysis. Eur J Cancer 44: 2122-2132
6. Ridker PM et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207
7. Platz EA et al. (2006) Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 98: 1819-1825